These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19273678)

  • 1. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
    Sáez-Llorens X; Yogev R; Arguedas A; Rodriguez A; Spigarelli MG; De León Castrejón T; Bomgaars L; Roberts M; Abrams B; Zhou W; Looby M; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2009 May; 53(5):1912-20. PubMed ID: 19273678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.
    Blumer J; Rodriguez A; Sánchez PJ; Sallas W; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2010 May; 54(5):2032-41. PubMed ID: 20160046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir: review of clinical efficacy and safety.
    Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
    Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological profile of famciclovir.
    Crumpacker C
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
    Pue MA; Pratt SK; Fairless AJ; Fowles S; Laroche J; Georgiou P; Prince W
    J Antimicrob Chemother; 1994 Jan; 33(1):119-27. PubMed ID: 8157552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir: a focus on efficacy and safety.
    Mubareka S; Leung V; Aoki FY; Vinh DC
    Expert Opin Drug Saf; 2010 Jul; 9(4):643-58. PubMed ID: 20429777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.
    Block SL; Yogev R; Waldmeier F; Hamed K
    Pediatr Infect Dis J; 2011 Jun; 30(6):525-8. PubMed ID: 21178655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 15. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
    Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
    Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
    Alster TS; Nanni CA
    Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of herpes simplex and varicella-zoster virus infections.
    Erlich KS
    West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.